Skip to main content
Log in

Concomitant Nonfunctional Pancreatic Neuroendocrine Tumor and Gastric GIST in a Patient Without Neurofibromatosis Type 1

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Abbreviations

CT:

Computed tomography

GIST:

Gastrointestinal stromal tumor

NF-1:

Neurofibromatosis type 1

pNET:

Pancreatic neuroendocrine tumor

References

  1. Alabraba E et al. Pancreatic insulinoma co-existing with gastric GIST in the absence of neurofibromatosis-1. WJSO. 2009;7:18.

    Google Scholar 

  2. Bosman FT, Carneiro F, Hruban RH. WHO classification of tumours of the digestive system. Lyon: IARC; 2010.

    Google Scholar 

  3. Breiner JA et al. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet. 2000;120(2):111.

    Article  PubMed  CAS  Google Scholar 

  4. Demetri GD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. NEJM. 2002;347(7):472.

    Article  PubMed  CAS  Google Scholar 

  5. Furlan D et al. Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract. Clin Cancer Res. 2004;10(3):947.

    Article  PubMed  CAS  Google Scholar 

  6. Gunawan B et al. Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. Hum Pathol. 2002;33(3):316.

    Article  PubMed  Google Scholar 

  7. Heinrich MC et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708.

    Article  PubMed  CAS  Google Scholar 

  8. Hirota S et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577.

    Article  PubMed  CAS  Google Scholar 

  9. Jiao Y et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331(6021):1199.

    Article  PubMed  CAS  Google Scholar 

  10. Kim do H et al. Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors. Genes Chromosomes Cancer. 2008;47(1):84.

    Article  PubMed  Google Scholar 

  11. Kindblom LG et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152(5):1259.

    PubMed  CAS  Google Scholar 

  12. Kover E et al. Dual tumours in the GI tract: synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms. Magy Onkol. 2004;48(4):315.

    PubMed  Google Scholar 

  13. Maertens O et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet. 2006;15(6):1015.

    Article  PubMed  CAS  Google Scholar 

  14. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1466.

    PubMed  CAS  Google Scholar 

  15. Missiaglia E et al. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol. 2010;28(2):245.

    Article  PubMed  CAS  Google Scholar 

  16. Pagogna S, Zanini N, Tomassetti P. Neuroendocrine tumor of the pancreas and GIST: is there a correlation? J Pancreas. 2004;6:501.

    Google Scholar 

  17. Rindi G, Wiedenmann B. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol 2011. doi:10.1038/nrendo.2011.120.

  18. Rosok BI et al. Single-centre experience of laparoscopic pancreatic surgery. BJS. 2010;97(6):902.

    Article  CAS  Google Scholar 

  19. Tonnies H et al. Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation. Gut. 2001;48(4):536.

    Article  PubMed  CAS  Google Scholar 

  20. van der Zwan SM, DeMatteo RP. Gastrointestinal stromal tumor: 5 years later. Cancer. 2005;104(9):1781.

    Article  PubMed  Google Scholar 

  21. Wallace MR et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990;249(4965):181.

    Article  PubMed  CAS  Google Scholar 

  22. Ward BA, Gutmann DH. Neurofibromatosis 1: from lab bench to clinic. Pediatr Neurol. 2005;32(4):221.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Prof. Sverre Heim, M.D., Ph.D., for analysing the cytogenetic data, Prof. Tor Jacob Eide, M.D., Ph.D., for performing the histopathology of the pNET and Dr. Jan Gunnar Fjeld, M.D., for analysing the data from the indium-111-labelled octreotide scintigraphy.

Competing Interests

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sven-Petter Haugvik.

Additional information

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haugvik, SP., Røsok, B.I., Edwin, B. et al. Concomitant Nonfunctional Pancreatic Neuroendocrine Tumor and Gastric GIST in a Patient Without Neurofibromatosis Type 1. J Gastrointest Canc 43 (Suppl 1), 171–174 (2012). https://doi.org/10.1007/s12029-011-9344-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-011-9344-3

Keywords

Navigation